Archives
-
Multi-Omics Mechanisms of HSYC Against Ovarian Aging in Mice
2026-08-04
This study uses integrative multi-omics analysis to reveal how He's Yangchao formula (HSYC), a traditional Chinese medicine, mitigates ovarian aging in naturally aged mice. By linking gut microbiota, metabolic, and transcriptomic changes, the research highlights glutathione metabolism as a key therapeutic pathway, offering new mechanistic insights for reproductive aging intervention.
-
PD 173074 Selectively Blocks FGF-2 Neurotrophic Effects in N
2026-08-04
This study demonstrates that PD 173074 acts as a potent, highly selective FGFR1 inhibitor, effectively antagonizing FGF-2-mediated neurotrophic and neurotropic responses in central nervous system neurons. The findings clarify PD 173074’s value as a molecular tool for dissecting FGFR signaling in neuronal development, with broad methodological implications for neuroscience and disease modeling.
-
Genotyping Kit for Target Alleles: Streamlined PCR from Inse
2026-08-03
Accelerate your genotyping workflows with the Genotyping Kit for target alleles of insects, tissues, fishes and cells. This kit eliminates lengthy DNA extraction steps, enabling rapid, contamination-resistant PCR analysis for modern molecular biology and disease modeling.
-
Streptavidin-FITC: Precision Tools for Translational Nanobio
2026-08-03
This thought-leadership article explores the mechanistic and strategic roles of Streptavidin-FITC in enabling high-sensitivity tracking of biotinylated molecules, particularly in the context of intracellular trafficking and lipid nanoparticle research. We synthesize recent peer-reviewed findings, benchmark APExBIO’s Streptavidin – FITC against evolving assay needs, and offer actionable guidance for translational researchers aiming to bridge cell biology, advanced imaging, and therapeutic development.
-
Cediranib (AZD2171) for Precision VEGFR Signaling in Cancer
2026-08-02
Cediranib (AZD2171) empowers translational cancer research by enabling precise, reproducible inhibition of VEGFR-mediated angiogenesis. This guide details practical workflows, advanced applications, and troubleshooting strategies to maximize the scientific value of Cediranib in in vitro models.
-
Angiotensin 1/2 (2-7) Peptide: Precision Tools for RAS and V
2026-08-01
Delve into the molecular specificity of Angiotensin 1/2 (2-7) peptide in renin-angiotensin signaling and viral entry research. This article uniquely dissects its assay performance, mechanistic insight, and translational relevance for blood pressure regulation and SARS-CoV-2 studies.
-
Network Pharmacology Reveals SRC/PI3K/AKT in Glioma Suppress
2026-07-31
This study applies network pharmacology to dissect how Shenqi Fuzheng injection (SFI) inhibits glioma proliferation and migration, identifying the SRC/PI3K/AKT signaling pathway as a critical mediator. The findings provide new molecular insight into SFI's anti-glioma activity and highlight implications for anti-angiogenic and tumor growth research.
-
Sunitinib in Renal Cell Carcinoma: Ferroptosis and Precision
2026-07-31
Explore the role of Sunitinib as a multi-targeted receptor tyrosine kinase inhibitor in renal cell carcinoma research. This article synthesizes new evidence on ferroptosis, TRIB3 knockdown, and resistance mechanisms to guide advanced experimental design.
-
Hoechst 33342/PI Double Staining Kit: Precision in Apoptosis
2026-07-30
Explore how the Hoechst 33342/PI Double Staining Kit enables advanced, quantitative discrimination of apoptosis and necrosis through chromatin and membrane integrity analysis. This article delivers unique strategic guidance for optimizing fluorescent cell death assays in translational research.
-
Synthetic mRNA Enables Rapid hiPSC Differentiation to Oligod
2026-07-30
This study demonstrates a non-integrative, synthetic mRNA-driven protocol for efficiently differentiating human iPSCs into functional oligodendrocytes. The use of modified OLIG2 mRNA overcomes the limitations of viral methods, offering a safer and more reproducible strategy for cell-based neuroregenerative research.
-
Cediranib (AZD2171): Applied Workflows for Angiogenesis Inhi
2026-07-29
Cediranib (AZD2171) is redefining precision in angiogenesis inhibition, enabling advanced in vitro cancer research with robust VEGFR pathway targeting and nuanced PI3K/Akt/mTOR signaling control. This guide translates latest findings into actionable protocols, workflow upgrades, and troubleshooting strategies to maximize experimental clarity and translational value.
-
Ellagic Acid in CK2 Pathway Research: Protocols & Innovation
2026-07-29
Ellagic acid stands out as a selective ATP-competitive CK2 inhibitor, enabling precise dissection of cancer and senescence pathways. This guide translates cutting-edge findings and validated protocols into actionable workflows for oxidative stress and apoptosis research, leveraging APExBIO’s reagent quality.
-
mTORC1-IRE1α Axis Drives Palmitate Lipotoxicity in Hepatocyt
2026-07-28
This study uncovers how palmitate, a saturated fatty acid, triggers hepatocyte cell death and triglyceride secretion through coordinated activation of the mTORC1-IRE1α pathway. The findings highlight mTORC1-IRE1α signaling as a mechanistic target in metabolic disorders involving lipotoxicity, supporting future efforts to design hepatoprotective interventions.
-
LncRNA FAISL Shields FAK from Calpain-2 to Drive TNBC Progre
2026-07-28
This study uncovers how lncRNA FAISL preserves FAK protein stability by inhibiting Calpain-2-mediated proteolysis, thereby promoting triple negative breast cancer (TNBC) progression and metastasis. The findings highlight a novel regulatory axis and a potential therapeutic target for aggressive breast cancer.
-
Ceftazidime in Gram-Negative Infection Research: Protocols &
2026-07-27
Ceftazidime, a third-generation cephalosporin, unlocks robust experimental workflows against multidrug-resistant Gram-negative bacteria, especially Pseudomonas aeruginosa. This article delivers actionable protocols, troubleshooting insights, and the latest evidence on resistance gene dynamics to empower reproducible research and translational breakthroughs.